YBX1 and breast carcinoma: Goodarzi et al. [41] discovered that tsRNAs from tRNAGlu, tRNAAsp, tRNAGly, and tRNATyr could inhibit the stability of multiple proto-oncogene transcripts in breast cancer cells by competitively binding to the RNA-binding protein YBX1.